5.9(Q2)
CiteScore
31
h-index

Evaluation of the Antidiabetic Potential of Rhizophora stylosa Leaf Extract through Enzyme Inhibition and In Vivo Metabolic Modulation

Document Type : Original Research Article

Authors

1 Faculty of Pharmacy, Universitas Muhammadiyah Surakarta, Surakarta, Indonesia

2 Faculty of Health Sciences, Universitas Muhammadiyah Pekajangan, Pekalongan, Indonesia

10.48309/ajca.2026.571765.2031
Abstract
Rhizophora stylosa, a mangrove plant, holds ethnopharmacological promise, but its comprehensive antidiabetic mechanism remains underexplored. This study employed an integrated experimental approach to comprehensively assess the antidiabetic potential of Rhizophora stylosa leaf extract (RSLE), investigating its effects on key enzymes, intestinal glucose handling, and systemic glucose metabolism. Twenty-eight healthy male rats (n=4 per group) were allocated into seven groups: normal control (CN, vehicle), positive control (PC, acarbose 4.5 mg/kg BW), and five treatment groups (T1-T5) receiving RSLE at 5, 10, 50, 100, and 200 mg/kg BW, respectively. Assessments included in vitro α-amylase and α-glucosidase inhibition assays, an ex vivo everted intestinal sac model for glucose absorption, in vivo oral and intraperitoneal glucose tolerance tests (OGTT/IPGTT), plasma insulin measurement via enzyme-linked immunosorbent assay (ELISA), and histochemical analysis of hepatic and muscle glycogen using PAS staining. RSLE demonstrated in vitro inhibition of α-glucosidase (IC50 = 190.08 µg/mL) and α-amylase (IC50 = 76.65 µg/mL). Ex vivo, RSLE (200 mg/kg) potently inhibited intestinal glucose absorption. In vivo, RSLE at 50 mg/kg effectively moderated postprandial glucose levels in an OGTT, while the 200 mg/kg dose significantly enhanced glucose clearance in an IPGTT. Insulin profiling revealed RSLE modulated secretion, eliciting an acute increase followed by a rapid decline correlating with glucose normalization. Furthermore, RSLE treatment significantly reduced hepatic glycogen storage but did not significantly affect muscle glycogen levels. RSLE exerts antidiabetic effects via an in vitro and in vivo approach, reducing intestinal glucose uptake, enhancing peripheral glucose disposal, and modulating insulin secretion. These findings substantiate its traditional use and highlight its potential as a source of antidiabetic agents.

Graphical Abstract

Evaluation of the Antidiabetic Potential of Rhizophora stylosa Leaf Extract through Enzyme Inhibition and In Vivo Metabolic Modulation

Keywords

Subjects


OPEN ACCESS

©2026 The author(s). This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit: http://creativecommons.org/licenses/by/4.0/

PUBLISHER NOTE

Sami Publishing Company remains neutral concerning jurisdictional claims in published maps and institutional affiliations.

CURRENT PUBLISHER

Sami Publishing Company

[1] Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B.B., Stein, C., Basit, A., Chan, J.C., Mbanya, J.C. IDF diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Research and Clinical Practice, 2022, 183, 109119.
[2] Chairunnisa, A., Haryoto, H., Abdul, A. Antidiabetic activities and phytochemical screening of broccoli plants (brassica oleracea L. Var. Italica). Journal of Nutraceuticals and Herbal Medicine, 2024, 1–13.
[3] Fajriyah, N., Mugiyanto, E., Rahmasari, K., Nur, A., Najihah, V., Wihadi, M.N., Merzouki, M., Challioui, A., Vo, T. Indonesia herbal medicine and its active compounds for anti-diabetic treatment: A systematic mini review. Moroccan Journal of Chemistry, 2023, 11(04), 2948–2964.
[4] Li, D.-L., Li, X.-M., Peng, Z.-Y., Wang, B.-G. Flavanol derivatives from rhizophora stylosa and their DPPH radical scavenging activity. Molecules, 2007, 12(5), 1163–1169.
[5] Susiloningsih, T., Christijanti, W., Marianti, A., WH, N. Ethanolic extract of tamarindus indica leaves lowers total cholesterol, triglycerides, and HDL but without affecting LDL in hyperlipidemic rats. Bioeksperimen: Jurnal Penelitian Biologi, 2025, 11(2), 126–138.
[6] Adhikari, A., Ray, M., Das, A.K., Sur, T.K. Antidiabetic and antioxidant activity of rhizophora mucronata leaves (indian sundarban mangrove): An: In vitro: And: In vivo: Study. AYU (An International Quarterly Journal of Research in Ayurveda), 2016, 37(1), 76–81.
[7] Muhtadi, M., Pambudi, D., Maryati, M. Mechanistic insight into medicinal properties of indonesian diverse mangrove species: A review. International Journal of Applied Pharmaceutics, 2024, 16, 1–8.
[8] Efendi, A., Aini, Halid, I., Ustiawaty, J. Effect of rhizophora sp mangrove leaf extract on mice blood glucose levels. IOP Conference Series: Earth and Environmental Science, 2021, 712(1), 012039.
[9] Miranti, D.I., Ichiura, H., Ohtani, Y. The bioactive compounds and antioxidant activity of food products of rhizophora stylosa fruit (coffee and tea mangrove). International Journal of Forestry Research, 2018, 2018(1), 2315329.
[10] Sok Yen, F., Shu Qin, C., Tan Shi Xuan, S., Jia Ying, P., Yi Le, H., Darmarajan, T., Gunasekaran, B., Salvamani, S. Hypoglycemic effects of plant flavonoids: A review. Evidence‐Based Complementary and Alternative Medicine, 2021, 2021(1), 2057333.
[12] Papuc, C., Goran, G.V., Predescu, C.N., Tudoreanu, L., Ștefan, G. Plant polyphenols mechanisms of action on insulin resistance and against the loss of pancreatic beta cells. Critical Reviews in Food Science and Nutrition, 2021, 62(2), 325–352.
[13] Feunaing, R.T., Tamfu, A.N., Gbaweng, A.J.Y., Mekontso Magnibou, L., Ntchapda, F., Henoumont, C., Laurent, S., Talla, E., Dinica, R.M. In vitro evaluation of α-amylase and α-glucosidase inhibition of 2, 3-epoxyprocyanidin C1 and other constituents from pterocarpus erinaceus poir. Molecules, 2022, 28(1), 126.
[14] Mugiyanto, E., Cahyanta, A.N., Putra, I., Setyahadi, S., Simanjuntak, P. Identifying active compounds of soursop ethanolic fraction as α-glucosidase inhibitor. Pharmaciana, 2019, 9(2), 191–200.
[15] Muhtadi, M., Haryoto, H., Sujono, T.A., Suhendi, A. Antidiabetic and antihypercholesterolemia activities of rambutan (nephelium lappaceum L.) and durian (durio zibethinus murr.) fruit peel extracts. Journal of Applied Pharmaceutical Science, 2016, 6(4), 190–194.
[16] Uddin, N., Hasan, M.R., Hossain, M.M., Sarker, A., Hasan, A.N., Islam, A.M., Chowdhury, M.M.H., Rana, M.S. In vitro α–amylase inhibitory activity and in vivo hypoglycemic effect of methanol extract of citrus macroptera montr. Fruit. Asian Pacific Journal of Tropical Biomedicine, 2014, 4(6), 473–479.
[17] Muhtadi, M., Annissa, Y.N., Suhendi, A., Sutrisna, E. Hypoglycemic effect of zingiber zerumbet ethanolic extracts and channa striata powder in alloxan-induced diabetic rats. Journal of Nutraceuticals and Herbal Medicine, 2018, 1(1), 9–15.
[18] Adeneye, A., Ajagbonna, O., Adeleke, T., Bello, S. Preliminary toxicity and phytochemical studies of the stem bark aqueous extract of musanga cecropioides in rats. Journal of Ethnopharmacology, 2006, 105(3), 374–379.
[19] Luo, Z., Liu, Y., Zhao, B., Tang, M., Dong, H., Zhang, L., Lv, B., Wei, L. Ex vivo and in situ approaches used to study intestinal absorption. Journal of Pharmacological and Toxicological Methods, 2013, 68(2), 208–216.
[20] Warri, A.O., Moke, E.G., Balogun, A.O., Nzeh, K.C., Umukoro, E.K., Erhirhie, E.O. Acute toxicity and hypoglycemic effect of a polyherbal formulation on blood glucose in oral glucose tolerance test (OGTT) and alloxan-induced diabetic rats. Biology, Medicine, & Natural Product Chemistry, 2021, 10(2), 111–115.
[21] Wang, L., Zhang, X.T., Zhang, H.Y., Yao, H.Y., Zhang, H. Effect of vaccinium bracteatum thunb. Leaves extract on blood glucose and plasma lipid levels in streptozotocin-induced diabetic mice. Journal of Ethnopharmacology, 2010, 130(3), 465–469.
[22] Mateer, S.W., Cardona, J., Marks, E., Goggin, B.J., Hua, S., Keely, S. Ex vivo intestinal sacs to assess mucosal permeability in models of gastrointestinal disease. Journal of Visualized Experiments: JoVE, 2016, 108), 53250.
[23] Eidi, M., Eidi, A., Zamanizadeh, H. Effect of salvia officinalis l. Leaves on serum glucose and insulin in healthy and streptozotocin-induced diabetic rats. Journal of Ethnopharmacology, 2005, 100(3), 310–313.
[24] Luciano, G., Luigi, G., Massimo, D.F., Gianluca, M.T., Alessandro, B., Paolo, S. Detection of bacteria in dental samples using the periodic acid-schiff (PAS) histological stain. Micron, 2023, 172, 103498.
[25] Adelusi, S.A., Falodun, A. Pharmacokinetics of chloroquine in diabetic rabbits. Journal of Pharmacy & Bioresources, 2008, 5(1), 6-11.
[27] Andersen, P.L., Vermette, P. Intracellular insulin quantification by cell-elisa. Experimental Cell Research, 2016, 347(1), 14–23.
[28] Tuan, N.N., Thi, H.N., My, C.L.T., Hai, T.X., Trung, H.T., Kim, A.N.T., Tan, T.N., Van, T.L., Nguyen, C.Q., Tran, Q.D. Inhibition of α-glucosidase, acetylcholinesterase, and nitric oxide production by phytochemicals isolated from millettia speciosa—in vitro and molecular docking studies. Plants, 2022, 11(3), 388.
[29] Falodun, A., Alemika, T.E., Igbanugo, J.S., Odili, V. Quantitative evaluation of sugars in some fruits consumed by patients with type 2 diabetes mellitus in jos metropolis. Journal of Pharmacy & Bioresources, 2011, 8(1), 27–33.
[30] Rendell, M.S. Current and emerging gluconeogenesis inhibitors for the treatment of type 2 diabetes. Expert Opinion on Pharmacotherapy, 2021, 22(16), 2167–2179.
[31] Agnarelli, A., Natali, M., Garcia-Gil, M., Pesi, R., Tozzi, M.G., Ippolito, C., Bernardini, N., Vignali, R., Batistoni, R., Bianucci, A.M. Cell-specific pattern of berberine pleiotropic effects on different human cell lines. Scientific Reports, 2018, 8(1), 10599.
[32] Weir, G.C., Bonner-Weir, S. A dominant role for glucose in β cell compensation of insulin resistance. The Journal of Clinical Investigation, 2007, 117(1), 81–83.
[33] Lv, W., Wang, X., Xu, Q., Lu, W. Mechanisms and characteristics of sulfonylureas and glinides. Current topics in Medicinal Chemistry, 2020, 20(1), 37–56.
[34] Bansal, P., Wang, Q. Insulin as a physiological modulator of glucagon secretion. American Journal of Physiology-Endocrinology and Metabolism, 2008, 295(4), E751–E761

Articles in Press, Accepted Manuscript
Available Online from 23 February 2026

  • Receive Date 20 January 2026
  • Revise Date 06 February 2026
  • Accept Date 16 February 2026